Vaxtex Cotfab quarterly results and financials

Vaxtex Cotfab (VCL)₹1.58+2.60%(9 Nov 2026 close)Garments & Apparels

Key facts

In the Jun 2026 quarter (standalone), Vaxtex Cotfab reported sales of ₹0 Cr and net profit of −₹0.04 Cr, down 119.0% year on year. For the year to Mar 2026, sales were ₹11.13 Cr and net profit ₹5.51 Cr.

Sales (Jun 2026): ₹0 Cr
Net profit (Jun 2026): −₹0.04 Cr
Sales (FY Mar 2026): ₹11.13 Cr
Net profit (FY Mar 2026): ₹5.51 Cr
EPS (Jun 2026): ₹0.00
Borrowings (Mar 2026): ₹5.25 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Vaxtex Cotfab quarterly results

₹ crore unless stated; each column is a quarter.

Vaxtex Cotfab Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	4.09	2.07	−0.39	0.00	0.00	0.00	5.23	0.00	2.28	8.85	0.00	0.00
Expenses	3.94	10.73	0.81	−0.10	0.10	0.36	5.33	0.22	2.39	6.56	0.10	0.09
Operating Profit	0.18	−8.66	−1.23	0.10	−0.12	−0.38	−0.10	−0.22	−0.12	2.32	−0.10	−0.09
OPM %	4.1%	−415.4%	—	—	—	—	−1.7%	—	−4.8%	26.0%	—	—
Other Income	0.00	0.01	0.43	0.01	0.02	0.00	1.05	0.45	0.73	1.55	0.49	0.01
Interest	0.01	0.00	0.00	0.01	0.01	0.01	0.05	0.01	0.01	0.01	0.01	0.00
Depreciation	0.06	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.10	−8.66	−0.80	0.09	−0.12	−0.45	0.91	0.23	0.61	3.87	0.40	−0.08
Tax %	22.1%	0.0%	−19.1%	0.0%	0.0%	−11.4%	−47.8%	0.0%	5.0%	−2.4%	−100.1%	−28.6%
Net Profit	0.06	−8.60	−0.64	0.07	−0.11	−0.38	1.31	0.21	0.56	3.94	0.78	−0.04
EPS (Rs)	0.00	−0.46	−0.05	0.00	0.00	−0.01	0.06	0.02	0.02	0.20	0.05	0.00

Vaxtex Cotfab profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Vaxtex Cotfab Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.62	4.42	18.41	21.91	27.69	26.09	61.74	75.35	16.58	5.23	11.13	11.13
Expenses	0.66	4.40	18.09	21.02	26.40	24.72	58.86	75.79	23.01	5.74	9.29	9.14
Operating Profit	−0.03	0.03	0.38	0.95	1.38	1.45	3.02	−0.16	−6.41	−0.51	1.90	2.01
OPM %	−3.2%	0.5%	2.0%	4.3%	5.0%	5.5%	4.9%	−0.2%	−38.5%	−9.5%	16.9%	18.1%
Other Income	0.02	0.02	0.00	0.04	0.01	0.05	0.37	2.21	−2.20	1.12	3.25	2.78
Interest	0.00	0.00	0.00	0.00	1.05	1.08	1.07	0.62	0.06	0.10	0.06	0.03
Depreciation	0.00	0.00	0.09	0.10	0.13	0.14	0.29	0.27	0.14	0.09	0.01	0.00
Profit before tax	0.02	0.05	0.28	0.88	0.20	0.27	2.02	1.17	−8.86	0.43	5.08	4.80
Tax %	0.0%	49.9%	37.0%	31.0%	52.6%	30.7%	26.3%	2.6%	0.0%	−111.9%	−9.3%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	−3.01	0.00	0.00	—
Net Profit	0.00	0.01	0.16	0.59	0.08	0.17	1.48	1.12	−8.80	0.87	5.51	5.24
EPS (Rs)	0.02	0.03	0.16	0.59	0.00	0.00	0.11	0.05	−0.49	0.04	0.31	0.27
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Vaxtex Cotfab balance sheet

₹ crore, at each year end.

Vaxtex Cotfab Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.39	0.39	0.39	0.41	0.41	6.01	6.03	10.05	12.64	18.39	18.39	18.39
Reserves	3.54	3.52	3.55	3.71	4.34	2.62	2.86	0.31	10.86	0.41	−0.03	4.08
Borrowings	0.00	0.00	0.00	0.24	3.28	12.57	10.27	7.43	5.18	11.48	11.10	5.25
Other Liabilities	0.00	0.28	0.76	5.82	5.47	6.68	2.53	6.19	40.66	18.55	18.95	9.06
Total Liabilities	3.93	4.19	4.70	10.18	13.50	27.88	21.69	23.98	69.34	48.83	48.41	36.78
Fixed Assets	0.00	0.00	0.37	1.71	1.81	2.38	3.86	3.91	3.66	1.15	1.05	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.06	0.00	0.00	0.00	0.00	0.13	0.09	1.06	1.11	7.04	7.56	1.33
Other Assets	3.87	4.19	4.33	8.47	11.69	25.37	17.74	19.01	64.57	40.64	39.80	35.45
Inventories	0.00	0.09	0.39	1.28	0.61	4.09	1.70	5.40	1.33	0.20	0.00	7.12
Trade receivables	0.15	0.22	1.70	3.09	4.71	8.56	9.82	6.21	18.27	15.74	14.00	7.10
Cash & equivalents	0.12	0.28	0.05	0.37	0.54	0.20	0.12	0.16	0.10	0.03	0.00	0.06
Total Assets	3.93	4.19	4.70	10.18	13.50	27.88	21.69	23.98	69.34	48.83	48.41	36.78

Vaxtex Cotfab cash flow

₹ crore, for each year.

Vaxtex Cotfab Cash flow
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.14	−3.42	1.52	1.73	−7.41	0.94	6.75	−10.93	−47.70	1.24	−1.70
Cash from investing activity	0.00	3.18	−1.43	−4.56	−5.04	2.39	−3.69	0.33	29.74	−0.75	5.74
Cash from financing activity	0.04	0.00	0.26	3.03	12.13	−3.42	−3.02	10.53	17.79	−0.50	−3.57
Net cash flow	0.15	−0.21	0.31	0.16	−0.33	−0.07	0.03	−0.05	−0.06	−0.01	0.49
Capex	0.00	0.36	1.43	0.20	0.70	1.61	0.35	0.01	6.38	0.00	0.00
Free cash flow	0.12	−3.77	0.06	1.50	−8.07	−0.68	6.36	−10.87	−51.13	1.22	0.42
CFO / OP %	−649.9%	−16,999.9%	422.1%	209.1%	−536.0%	67.1%	240.1%	7,587.1%	744.1%	−254.0%	−83.9%

Vaxtex Cotfab ratios

Working-capital days and returns, by year.

Vaxtex Cotfab Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	122	139	61	78	112	137	36	88	345	972	232
Inventory days	—	64	35	35	16	71	28	37	7	4	0	300
Days payable	—	159	53	133	126	104	36	35	152	293	—	364
Cash conversion cycle	—	27	122	−37	−32	79	130	39	−57	56	973	167
Working capital days	—	28	289	44	15	87	210	67	115	458	1,176	752
ROCE %	0.0%	0.3%	1.0%	6.5%	14.3%	8.6%	6.7%	16.8%	2.0%	−20.7%	1.8%	18.0%

Vaxtex Cotfab: frequently asked questions

What are the latest quarterly results of Vaxtex Cotfab?

For the Jun 2026 quarter, Vaxtex Cotfab reported sales of ₹0 Cr and net profit of −₹0.04 Cr, down 119.0% year on year.

What is the annual revenue of Vaxtex Cotfab?

Vaxtex Cotfab's sales for the year to Mar 2026 were ₹11.13 Cr; over the last twelve months they were ₹11.13 Cr.

What is the net profit of Vaxtex Cotfab?

Net profit for the year to Mar 2026 was ₹5.51 Cr, and ₹5.24 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.27.

How much debt does Vaxtex Cotfab have?

Vaxtex Cotfab reported borrowings of ₹5.25 Cr at Mar 2026, against cash and equivalents of ₹0.06 Cr.

What is the free cash flow of Vaxtex Cotfab?

Cash from operations was −₹1.70 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.42 Cr.

Loading…